Understanding the Structure/Activity Relationships of the Iron Regulatory Peptide Hepcidin

Autor: Elizabeta Nemeth, Tomas Ganz, David J. Craik, Chia Chia Tan, Richard J. Clark, Gloria C. Preza
Jazyk: angličtina
Rok vydání: 2011
Předmět:
inorganic chemicals
congenital
hereditary
and neonatal diseases and abnormalities

Iron Overload
Iron
Clinical Biochemistry
Ferroportin
Molecular Sequence Data
Regulator
01 natural sciences
Biochemistry
digestive system
Article
03 medical and health sciences
Selenium
Structure-Activity Relationship
Hepcidins
Hepcidin
hemic and lymphatic diseases
Drug Discovery
Structure–activity relationship
Humans
Amino Acid Sequence
Disulfides
Molecular Biology
Peptide sequence
Cation Transport Proteins
030304 developmental biology
Pharmacology
0303 health sciences
biology
010405 organic chemistry
Chemistry
nutritional and metabolic diseases
General Medicine
0104 chemical sciences
3. Good health
Protein Structure
Tertiary

Hereditary hemochromatosis
biology.protein
Molecular Medicine
HAMP
Homeostasis
Antimicrobial Cationic Peptides
Popis: The peptide hormone hepcidin is a key homeostatic regulator of iron metabolism and involved in pathological regulation of iron in response to infection, inflammation, hypoxia and anaemia. It acts by binding to the iron exporter ferroportin, causing it to be internalised and degraded; however, little is known about the structure/activity relationships of the interaction of hepcidin with ferroportin. Here we show that there are key residues within the N-terminal region of hepcidin that influence its interaction with ferroportin, and we explore the structure/function relationships at these positions. We found that the interaction is primarily hydrophobic with critical stereochemical requirements at positions 4 and 6. In addition, a series of hepcidin mutants in which disulfide bonds had been replaced with diselenide bonds showed no change in biological activity compared to native hepcidin. The results provide mechanistic insight into the interaction between hepcidin and ferroportin and identify important constraints for the development of hepcidin congeners for the treatment of hereditary iron overload.
Databáze: OpenAIRE